TacticScaleWhat JD Health International Does & How It Makes Money (6618.HK)
Updated October 2026 · reflects JD Health International's latest reported financials
China's leading online pharmacy and digital healthcare platform. Most of its money comes from selling pharmaceutical and healthcare products through direct sales, an online marketplace and on-demand delivery.
How JD Health International makes money
Most of its money comes from selling pharmaceutical and healthcare products through direct sales, an online marketplace and on-demand delivery. It also charges merchants and advertisers for marketing, and earns fees from medical consultations, health services and technology solutions.
What JD Health International does
JD Health International, founded in 2014 and headquartered in Beijing, is a subsidiary of JD Jiankang Limited and runs one of China's major online healthcare platforms. Its core business is retailing pharmaceutical and healthcare products through direct sales, a third-party online marketplace and on-demand delivery, alongside related smart monitoring, respiratory therapy, senior-oriented and home medical devices and rapid testing products. Around this retail base, the company offers online medical consultations, hospital and doctor referrals, health check-ups, genetic testing, home care such as wound care and post-operative care, online medical insurance payment, and digital health solutions. It also operates offline examination and polyclinic centers and TCM wellness services, and earns marketing revenue from pharmaceutical and healthcare companies advertising on its platform.
Products & services
- Online pharmacy (direct sales and marketplace)
- On-demand medicine delivery
- Online medical consultation
- Health check-ups and genetic testing
- Home care and medical device services
- Offline examination and polyclinic centers
What is JD Health International worth?
A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.
We show a fair value only when the method is trustworthy. See JD Health International on TacticScale →